Article Information
vol. 7 no. 3
Published By
Online ISSN
History
- Received April 19, 2021
- Accepted June 4, 2021
- Published online August 2, 2021.
Article Versions
- previous version (June 17, 2021 - 07:22).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Valerie J. Ludbrook1⇑,
- Kate E. Hanrott1,
- James L. Kreindler2,
- Joanna E. Marks-Konczalik1†,
- Nick P. Bird1,
- Debbie A. Hewens1,
- Misba Beerahee1,
- David J. Behm2,
- Alyn Morice3,
- Lorcan McGarvey4,
- Sean M. Parker5,
- Surinder S. Birring6 and
- Jaclyn Smith7
- 1GlaxoSmithKline, Stevenage, UK
- 2GlaxoSmithKline, Upper Providence, USA
- 3Hull York Medical School, Cottingham, UK
- 4Queens University, Belfast, UK
- 5North Tyneside General Hospital, North Shields, UK
- 6Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK
- 7Division of Infection Immunity and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
- Corresponding author: Valerie Ludbrook (Valerie.J.Ludbrook{at}GSK.com)
Funding
US Federal Government funds from the Department of Health and Human Services (Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority)
HHSO100201700009CGlaxoSmithKline
Article usage
Altmetrics
Vol 7 Issue 3
Table of Contents
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
